Inactive Instrument

All News Endo Health Solutions Inc Nasdaq

Equities

US29264F2056

End-of-day quote Nasdaq Other stock markets
- ^USD	-

12:17pm	North American Morning Briefing : Stock Futures -2-	DJ
03-22	Fourth Amended Joint Reorganization Plan Approved for Endo International plc	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

North American Morning Briefing : Stock Futures -2-	11:17am	DJ
Endo International plc - Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution	04-23	AQ
Endo, Inc. Announces Proposed New Senior Secured Credit Facilities	04-02	AQ
Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS	03-27	AQ
Fourth Amended Joint Reorganization Plan Approved for Endo International plc	03-22	CI
Health Care Down on Rate Bias -- Health Care Roundup	03-20	DJ
News Highlights : Top Company News of the Day - Wednesday at 5 PM ET	03-20	DJ
Drugmaker Endo receives US court approval for bankruptcy restructuring	03-19	RE
Drugmaker Endo receives US court approval for bankruptcy restructuring, Bloomberg News reports	03-19	RE
Fourth Amended Joint Reorganization Plan Filed by Endo International plc	03-18	CI
Par Pharmaceutical Issues Voluntary Nationwide Recall of One Lot of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution	03-12	PR
North American Morning Briefing : Stock Futures -2-	03-11	DJ
Health Care Flat After Trial Setbacks -- Health Care Roundup	03-08	DJ
Endo International plc Reports Earnings Results for the Full Year Ended December 31, 2023	03-06	CI
Endo International plc Reports Property, Plant and Equipment Impairment Charges for the Three Months Ended December 31, 2023	03-06	CI
Endo International plc Provides Earnings Guidance for the Year 2024	03-06	CI
Endo International plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-06	CI
ENDO REPORTS FOURTH-QUARTER 2023 FINANCIAL RESULTS	03-06	PR
Drugmaker Endo reaches $465 mln bankruptcy settlement with US	02-29	RE
Endo Reaches Resolution with U.S. Department of Justice Regarding Legacy Marketing of Opana® ER	02-29	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Endo Health Solutions Inc Nasdaq

Equities

US29264F2056

All News

Filters